USPTO serial 79231411
Serial No. 79231411
Reviewed by CopyMark Law Group
Reg. 5635234Status 709
- Filing date
- Status date
- Registration date
- Dec 25, 2018
- Examiner
- O'BRIEN, JENNIFER LYNN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 79231411?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information; computer software for capturing and providing information concerning quality of medication and pharmaceuticals and reactions and events resulting from the use of medication and pharmaceuticals, enabling follow-up questions and answers regarding said quality, reactions and events and producing reports regarding such quality, reactions and events; computer programs for capturing and providing information concerning quality of medication and pharmaceuticals and reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said quality, reactions and events and for producing reports regarding such quality, reactions and events, computer software applications for mobile phones, smart phones, portable media players and handheld computers, namely, software for capturing information concerning quality of medication or pharmaceuticals, reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; computer software for the evaluation and analysis of data and information concerning the quality of medication and pharmaceuticals and the reactions and events resulting from the use of medication and pharmaceuticals | SECTION 71 - CANCELLED | — |
| 038 | Telecommunications services, namely, transmission of data by means of telecommunications networks, wireless communication networks and the Internet; telecommunication services for providing multiple user access to a global network; transfer of data by telecommunications; transmission and reception of database information via telecommunications networks; data transmission and reception services via telecommunications means; providing telecommunications connections to databases; electronic exchange of data stored in databases accessible via telecommunication networks; communication services, namely, providing electronic transmission of information stored in a database via interactively communicating computer systems; providing multiple use access to global computer information networks for the transfer and dissemination of a wide range of information; information transmission via electronic communications networks; providing multiple user access to proprietary collections of information by means of global computer information networks; telecommunications services, namely, electronic exchange of medical records between patients or health care professionals and pharmaceutical companies; telecommunication services, namely, providing access to an electronic exchange of medical records between patients or health care professionals and pharmaceutical companies | SECTION 71 - CANCELLED | — |
| 042 | Software as a service (SAAS) services featuring software for capturing and providing data concerning quality of medication and pharmaceuticals, reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; software as a service (SAAS) services featuring software for evaluating and analyzing data and information concerning the quality of medication and pharmaceuticals and the reactions and events resulting from the use of medication and pharmaceuticals; providing temporary use of on-line non-downloadable software which enables the capture of information concerning quality of medication and pharmaceuticals, reactions and events resulting from the use of medication and pharmaceuticals, which enables follow-up questions and answers regarding said quality, reactions and events and which enables the production of reports regarding said reactions and events; services for maintenance of computer software; providing temporary use of non-downloadable software allowing web site users to send and receive information concerning quality of medication and pharmaceuticals used, reactions and events resulting from the use of medication and pharmaceuticals, answer and read answers to follow-up questions regarding said quality, reactions and events and produce reports regarding said reactions and events; software as a service (SAAS) services featuring software for collecting, evaluating and analyzing data; design of computer software for reporting reactions and events resulting from the use of medication and pharmaceuticals; design of computer software for commercial analysis and reporting | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MyMedsandMe Limited
- Other trademarks owned by MyMedsandMe Limited
- Other trademarks owned by MyMedsandMe Limited
- Other trademarks in Class 009
- Other trademarks in Class 038
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 11, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 11, 2025 | C71T | CANCELLED SECTION 71 | — |
| Dec 25, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 26, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 8, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 8, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 25, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 25, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 9, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 9, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 6, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 19, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 19, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 19, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 5, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 23, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 23, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 21, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jul 31, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 31, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 2, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 16, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 16, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 15, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 12, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 11, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| May 9, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 4, 2018 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| May 3, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |